Insmed Incorporated reported $1.14B of revenue over the trailing twelve months, +186% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $1.14B (to Q2 2026). Net Income: −$875M, trailing twelve months to Q2 2026. Free Cash Flow: −$808M, trailing twelve months to Q2 2026. Op Margin: −107%, trailing twelve months to Q2 2026.

INSMInsmed Incorporated

HealthcareUSD

$124.36

$91.8852 weeks$211.41

INSM as reported

Insmed Incorporated reported $1.14B of revenue over the trailing twelve months, +186% on the year before. 10 reported series are charted on this page, each one as filed.

$1.14B

Revenue, trailing twelve months · to Q2 2026 · +186% against the twelve months before

Net Income: −$875M
Net Income · −15% year on year · trailing twelve months to Q2 2026
Free Cash Flow: −$808M
Free Cash Flow · −7.0% year on year · trailing twelve months to Q2 2026
Op Margin: −107%
Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for INSM, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$1.14B	+186%	Q2 2026
Net Income	−$875M	−15%	Q2 2026
EPS	−$4.10	−28%	Q2 2026
Gross Margin	83%	n/a	Q2 2026
Op Margin	−107%	n/a	Q2 2026
Net Margin	−110%	n/a	Q2 2026
ROE	−145%	n/a	Q2 2026
ROA	−51%	n/a	Q2 2026
ROIC	−802%	n/a	Q2 2026
Free Cash Flow	−$808M	−7.0%	Q2 2026